Cargando…
Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase
The inhibition of α-glucosidase and α-amylase is a clinical strategy for the treatment of type II diabetes, and herbal medicines have been reported to credibly alleviate hyperglycemia. Our previous study has reported some constituents from plant or herbal sources targeted to α-glucosidase and α-amyl...
Autores principales: | Riyaphan, Jirawat, Jhong, Chien-Hung, Lin, Shian-Ren, Chang, Chia-Hsiang, Tsai, May-Jwan, Lee, Der-Nan, Sung, Ping-Jyun, Leong, Max K., Weng, Ching-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225388/ https://www.ncbi.nlm.nih.gov/pubmed/30189596 http://dx.doi.org/10.3390/molecules23092260 |
Ejemplares similares
-
In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes
por: Riyaphan, Jirawat, et al.
Publicado: (2021) -
Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase
por: Altowyan, Mezna Saleh, et al.
Publicado: (2019) -
Synthesis and Inhibitory Effect of Some Indole‐Pyrimidine Based Hybrid Heterocycles on α‐Glucosidase and α‐Amylase as Potential Hypoglycemic Agents
por: Badria, Farid A., et al.
Publicado: (2019) -
Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors
por: Aguila-Muñoz, Dolores G., et al.
Publicado: (2023) -
Momilactones A and B Are α-Amylase and α-Glucosidase Inhibitors
por: Quan, Nguyen Van, et al.
Publicado: (2019)